[go: up one dir, main page]

SV2007002357A - Derivado de quinolina, su uso, preparacion y medicamento que lo contiene ref. p-sv-79232/ug - Google Patents

Derivado de quinolina, su uso, preparacion y medicamento que lo contiene ref. p-sv-79232/ug

Info

Publication number
SV2007002357A
SV2007002357A SV2005002357A SV2005002357A SV2007002357A SV 2007002357 A SV2007002357 A SV 2007002357A SV 2005002357 A SV2005002357 A SV 2005002357A SV 2005002357 A SV2005002357 A SV 2005002357A SV 2007002357 A SV2007002357 A SV 2007002357A
Authority
SV
El Salvador
Prior art keywords
preparation
quinolina
ref
derived
product containing
Prior art date
Application number
SV2005002357A
Other languages
English (en)
Inventor
Wolfgang Schwede
Antonius Ter Laak
Stefan Jaroch
Benjamin Bader
Roman Hillig
Dieter Zopf
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of SV2007002357A publication Critical patent/SV2007002357A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UN DERIVADO DE QUINOLINA DE LA FORMULA GENERAL A, VER FORMULA,EN LA QUE R1, R2, R3, X, Y, Z Y A SE INDICAN EN LA DESCRIPCION Y EN LAS REIVINDICACIONES, AL USO DE LOS COMPUESTOS LA FORMULA GENERAL A PARA EL TRATAMIENTO DE DIVERSAS ENFERMEDADES, ASI COMO A LA PREPARACION DE COMPUESTOS LA FORMULA GENERAL A
SV2005002357A 2004-12-22 2005-12-22 Derivado de quinolina, su uso, preparacion y medicamento que lo contiene ref. p-sv-79232/ug SV2007002357A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004063223A DE102004063223A1 (de) 2004-12-22 2004-12-22 Chinolinderivat, dessen Verwendung, Herstellung und dieses enthaltendes Arzneimittel

Publications (1)

Publication Number Publication Date
SV2007002357A true SV2007002357A (es) 2007-02-16

Family

ID=36599298

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2005002357A SV2007002357A (es) 2004-12-22 2005-12-22 Derivado de quinolina, su uso, preparacion y medicamento que lo contiene ref. p-sv-79232/ug

Country Status (7)

Country Link
CN (1) CN101087788A (es)
AR (1) AR052544A1 (es)
DE (1) DE102004063223A1 (es)
GT (1) GT200500381A (es)
PA (1) PA8657701A1 (es)
SV (1) SV2007002357A (es)
UY (1) UY29308A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103382206B (zh) * 2012-05-04 2016-09-28 上海恒瑞医药有限公司 喹啉或喹唑啉类衍生物、其制备方法及其在医药上的应用
CN106565823B (zh) * 2016-11-10 2020-09-11 珠海诺贝尔国际生物医药研究院有限公司 一种Eph受体小分子抑制剂及其制备方法
CN110577546B (zh) * 2018-06-08 2021-09-07 江苏威凯尔医药科技有限公司 Vegfr抑制剂及其制备方法和应用
WO2019233458A1 (zh) * 2018-06-08 2019-12-12 江苏威凯尔医药科技有限公司 Vegfr抑制剂及其制备方法和应用
CN113150009B (zh) * 2020-01-07 2023-05-23 爱科诺生物医药(香港)有限公司 一类具有程序性细胞坏死通路抑制活性的杂环化合物及其应用
CN113061142B (zh) * 2020-01-02 2024-08-27 爱科诺生物医药(香港)有限公司 一类具有程序性细胞坏死通路抑制活性的杂环化合物及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3919238A (en) * 1973-06-06 1975-11-11 Morton Norwich Products Inc 9-(Substituted amino)imidazo(4,5-f) quinolines
EP0187705A3 (en) * 1985-01-08 1988-05-11 Norwich Eaton Pharmaceuticals, Inc. Imidazo(4,5-f)quinolines useful as immunomodulating agents
FI940469A7 (fi) * 1991-08-02 1994-02-01 Pfizer Kinoliinijohdannaisia immunostimulantteina

Also Published As

Publication number Publication date
DE102004063223A1 (de) 2006-07-13
CN101087788A (zh) 2007-12-12
PA8657701A1 (es) 2006-09-08
GT200500381A (es) 2006-08-03
UY29308A1 (es) 2006-06-30
AR052544A1 (es) 2007-03-21

Similar Documents

Publication Publication Date Title
UY28369A1 (es) Agentes terapéuticos
CR9834A (es) [1,8]naftiridin-2-onas y compuestos relacionados para el tratamiento de la ezquizofrenia
UY30327A1 (es) Nuevos compuestos ii
UY31524A1 (es) Nuevos compuestos 010
CR6726A (es) Compuestos azapoliciclicos condensados con arilo
CR10304A (es) Compuestos de tetrahidropiridotienopirimidina y procedimientos de uso de los mismos
UY29886A1 (es) Derivados de pirazol novedosos, composiciones farmaccuticas que los contienen, procedimientos para la preparacinn de los mismos y aplicaciones
UY31481A1 (es) Nuevos derivados de pirimidina, procesos de preparacion, composiciones farmacéuticas conteniéndolos y aplicaciones
UY29795A1 (es) Derivados de adenina, composiciones farmacéuticas que los contienen, procesos de preparación y aplicaciones
UY28144A1 (es) Agentes terapéuticos
ECSP11011113A (es) Piridiloxi-indoles inhibidores del vegf-r2 y uso de los mismos para el tratamiento de enfermedades
CR10489A (es) Derivados fenil-pirazol como ligandos de receptores glucocorticoides no esteroides
CR9954A (es) Derivados de pirazina
HN2008001666A (es) Derivados acidos de cicloalquilamino
CR9223A (es) 18-metil-19-nor-17-pregn-4-en-21, 17-carbolactonas,asi como preparaciones farmaceuticas que las contienen
SV2007002007A (es) Compuestos de quinolina sustituidos ref. pc 25932a
PA8621901A1 (es) Derivados de sulfonamida para el tratamiento de enfermedades
UY30460A1 (es) Compuestos terapéuticos
UY29002A1 (es) Nuevos derivados de hidantoína, procesos parasu preparación, composiciones farmacéuticas que los contienen y su uso en terapia
ECSP099425A (es) Derivados de amina y su uso en enfermedades mediadas por el adrenorecetor beta 2
CR9182A (es) Derivado de quinolina, su uso, preparacion y medicamento que lo contiene
PA8568101A1 (es) Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos, y procedimientos para su uso
UY30451A1 (es) 18-metil-19-nor-androst-4-en-17,17-espiroéteres (18-metil-19-nor-20-espirox-4-en-3-onas),ase como preparaciones farmacéuticas que lo contienen.
HN2010000330A (es) DERIVADOS DE INDOL-2-ONA DISUSTITUIDOS EN 3 y SU PREPARACION
PA8589801A1 (es) Aminoalcoxiindoles

Legal Events

Date Code Title Description
FD Lapse